Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Article Discussing Interim Data Coming Soon

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Mar 11, 2024 7:42am

273 Views

Post# 35925909

RE:Article Discussing Interim Data Coming Soon

Eoganacht wrote: At 11:02 Dr. McFarland said:

"There should be an article coming out that's going to discuss the phase 2 interim data anytime. So if you're interested you can stay tuned."

Thanks Eoganacht, the expression " timing is everything " is one that should be paid attention to in this case! Dr. Sherri McFarland's article might occur within the period that we are expecting word on the FDA for Pre-BTD or even actual BTD approval. BTW where is Health Canada shouldn't they be first in approval?

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant